Skip to content
AwardedPRTGoods€47,394

261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )

Published
Published 13 July 2026

Overview

Unidade Local de Saúde Santa Maria procured bevacizumab (a monoclonal antibody medication) through this framework agreement, with the contract awarded to Cencora 3PL Portugal on 30 June 2026 for a value of €47,393.50. The procurement is now complete.

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€47,394
Procedure
Open
Published
13 July 2026
Classification (CPV)
Immune sera and immunoglobulins

Award outcome

Awarded value
€47,394
Award date
30 June 2026
Contract period
— → 27 December 2026
Winner
  • Cencora 3PL Portugal

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    13 July 2026

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab ) — won by Cencora 3PL Portugal — Skim